Neurodegeneration and epigenetics: A review

Xylaki, 2019, Epigenetics of the synapse in neurodegeneration, Curr Neurol Neurosci Rep, 10.1007/s11910-019-0995-y Hwang, 2017, The emerging field of epigenetics in neurodegeneration and neuroprotection, Nat Rev Neurosci, 347, 10.1038/nrn.2017.46 Jiang, 2008, Epigenetics in the nervous system, J Neurosci, 11753, 10.1523/JNEUROSCI.3797-08.2008 Fischer, 2007, Recovery of learning and memory is associated with chromatin remodelling, Nature, 178, 10.1038/nature05772 Schratt, 2009, MicroRNAs at the synapse, Nat Rev Neurosci, 842, 10.1038/nrn2763 Raveendra, 2018, Long noncoding RNA GM12371 acts as a transcriptional regulator of synapse function, Proc Natl Acad Sci USA, E10197 Miller, 2007, Covalent modification of DNA regulates memory formation, Neuron, 857, 10.1016/j.neuron.2007.02.022 Feng, 2010, Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons, Nat Neurosci, 423, 10.1038/nn.2514 Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 930, 10.1126/science.1170116 Migilior, 2009, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat Res, 82, 10.1016/j.mrfmmm.2008.10.011 Matsumoto, 2010, CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease, PLoS ONE, 5, 10.1371/journal.pone.0015522 Frieling, 2007, Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa, Mol Psychiatry, 12, 229, 10.1038/sj.mp.4001931 Jowead, 2010, Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients’ brains, J Neurosci, 30, 6355, 10.1523/JNEUROSCI.6119-09.2010 Desplats, 2011, α-Synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases, J Biol Chem, 286, 9031, 10.1074/jbc.C110.212589 Cai, 2011, Study of methylation levels of parkin gene promoter in Parkinson's disease patients, Int J Neurosci, 121, 497, 10.3109/00207454.2011.580866 Goers, 2003, Nuclear localization of α-synuclein and its interaction with histones, Biochemistry, 42, 8465, 10.1021/bi0341152 Kontopoulos, 2006, α-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity, Hum Mol Genet, 15, 3012, 10.1093/hmg/ddl243 Outeiro, 2007, Sirtuin2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease, Science, 317, 516, 10.1126/science.1143780 Vartiainen, 2006, Identification of gene expression changes in transgenic C. elegans overexpressing human α-synuclein, Neurobiol Dis, 22, 477, 10.1016/j.nbd.2005.12.021 Kim, 2007, A microRNA feedback circuit in midbrain dopamine neurons, Science, 317, 1220, 10.1126/science.1140481 Hiltunen, 2012, Genetics and epigenetics of Parkinson's disease, Sci World J, 2012 Asikainen, 2010, Global microRNA expression profiling of caenorhabditis elegans Parkinson's disease models, J Mol Neurosci, 41, 210, 10.1007/s12031-009-9325-1 Sanchez, 2018, Epigenetic study in Parkinson's disease: a pilot analysis of DNA methylation in candidate genes in brain, Cells, 7 Morales, 2017, Implication of DNA methylation in Parkinson's diseases, Front Mol Neurosci, 10 Tarale, 2017, Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson's disease-associated genes, Arch Toxicol, 91, 2629, 10.1007/s00204-016-1899-0 Broide, 2007, Distribution of histone deacetylases 1–11 in the rat brain, J Mol Neurosci, 31, 47, 10.1007/BF02686117 Guan, 2009, HDAC2 negatively regulates memory formation and synaptic plasticity, Nature, 55, 10.1038/nature07925 Liu, 2018, The epigenetics of Alzheimer's disease: factors and therapeutic implications, Front Genet, 10.3389/fgene.2018.00579 Ding, 2008, Histone deacetylase 6 interacts with the microtubule-associated protein tau, J Neurochem, 106, 2119, 10.1111/j.1471-4159.2008.05564.x Wang, 2018, Identifying circRNA-associated-ceRNA networks in the hippocampus of Abeta1-42induced Alzheimer's disease-like rats using microarray analysis, Aging, 10, 775, 10.18632/aging.101427 Lee, 2012, miR206 regulates brain-derived neurotrophic factor in Alzheimer disease model, Ann Neurol, 72, 269, 10.1002/ana.23588 Song, 2011, Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine, Nat Biotechnol, 29, 68, 10.1038/nbt.1732 Condliffe, 2014, Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain, Neurobiol Aging, 35, 1850, 10.1016/j.neurobiolaging.2014.02.002 Landles, 2004, Huntingtin and the molecular pathogenesis of Huntington's disease, EMBO Rep, 5, 958, 10.1038/sj.embor.7400250 Sadri-Vakili, 2007, Histones associated with downregulated genes are hypoacetylated in Huntington's disease models, Hum Mol Genet, 16, 1293, 10.1093/hmg/ddm078 Ryu, 2006, ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease, Proc Natl Acad Sci USA, 103, 19176, 10.1073/pnas.0606373103 Zsindely, 2018, Histone methylation in Huntington's disease: are bivalent promoters the clinical targets, Neural Regen Res, 13, 1191, 10.4103/1673-5374.235029 Hu, 2011, Transcriptional modulator H2A histone family, member Y(H2AFY) marks Huntington Disease activity in man and mouse, Proc Natl Acad Sci USA, 108, 17141, 10.1073/pnas.1104409108 Valor, 2013, Genomic landscape of transcription and epigenetic dysregulation in early dysregulation in early onset polyglutamine disease, J Neurosci, 10471, 10.1523/JNEUROSCI.0670-13.2013 Francelle, 2017, Contribution of neuroepigenetics to Huntington's disease, Front Hum Neurosci, 11, 10.3389/fnhum.2017.00017 Halfmann, 2010, Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits, Science, 330, 629, 10.1126/science.1191081 Burli, 2013, Design, synthesis, and biological evaluation of potent and selective class IIa Histone Deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease, J Med Chem, 56, 9934, 10.1021/jm4011884 Janczura, 2018, Inhibition of HDAC3 reverses Alzheimer's diseaserelated pathologies in vitro and in the 3xTg-AD mouse model, Proc Natl Acad Sci USA, 115, E11148, 10.1073/pnas.1805436115 Harrison, 2019, The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease, J Neurochem, 148, 136, 10.1111/jnc.14599 Pan, 2016, Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity, Sci Rep, 6